Shu Yang, Kelly E. Carstens, Ibukunoluwa Ipaye, et al. High-throughput cytokine detection platform for evaluation of chemical induced microglial activation. SLAS Technology. 2025;35. doi:10.1016/j.slast.2025.100347
S. Tori Ellison, Ian Hayman, Kristy Derr, et al. Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents. Nature Communications. 2025;16(1):9200. doi:10.1038/s41467-025-64245-w
William C. Wright, Min Pan, Gregory A. Phelps, et al. An open-source screening platform accelerates discovery of drug combinations. Nature Communications. 2025;16(1):11005. doi:10.1038/s41467-025-66223-8
Xiangling Meng, Noah Reis, Michael C. Bassik, Sergiu P. Pașca. CRISPR screens in human neural organoids and assembloids. Nature Protocols. 2025:1-21. doi:10.1038/s41596-025-01299-6
Patricia R. Pitrez, Luis M. Monteiro, Oliver Borgogno, Xavier Nissan, Jerome Mertens, Lino Ferreira. Cellular reprogramming as a tool to model human aging in a dish. Nature Communications. 2024;15(1):1816. doi:10.1038/s41467-024-46004-5
Jack W. Scannell, James Bosley, John A. Hickman, et al. Predictive validity in drug discovery: what it is, why it matters and how to improve it. Nature Reviews Drug Discovery. 2022;21(12):915-931. doi:10.1038/s41573-022-00552-x